|
|
 |
Conference Introduction |
| CTIC Capital is committed to create valuable connections for US companies that are interested in raising
capital and developing business relationships in China. |
|
|
|
 |
Get ready to pitch We will bring you Chinese investors (100+) who are actively searching for US investment and business collaboration opportunities. |
| |
 |
Get ready to be inspired
Impressive line up of investors from US and China to share challenges and opportunities in areas such as: Precision Medicine, Early Drug Development, Medical Devices, Cross Border M&A, Fund Raising and more. |
| |
 |
Get ready to connect Mobile APP would assist you in submitting inquiries of one-on-one investors meetings before and during the conf--erence. |
|
|
|
|
| |
CONFIRMED SPEAKERS |
 |
|
|
 |
| ROBERT S. LANGER |
| The David H. Koch Institute Professor,
Massachusetts Institute of Technology |
|
|
|
|
|
|
|
|
|
|
|
|
 |
| CHEN YU |
Managing Partner,
Vivo Capital |
|
|
|
|
|
|
 |
| STEVEN WANG |
Managing and Founding Partner,
HighLight Capital |
|
|
|
|
 |
| VICTOR SHI |
| Founding President, QIAGEN Asia Pacific; General Partner, Serica Capital |
|
|
|
|
|
|
|
|
 |
| YAOMING LIANG |
| Chairman of the Board and CEO, KingsMed Diagnostics |
|
|
|
|
 |
| RICHARD ZHAO |
| Investment & Sr. Vice President, Medical Device, Fosun Pharma |
|
|
|
|
|
|
 |
| KEWEN JIN |
Chairman, BayHelix,
Managing Partner, Serica Capital |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
| DAJUN YANG |
M.D., Ph.D., Chairman & CEO
Ascentage Pharma Group |
|
|
|
|
 |
| BIN SUN |
Head and Managing Director,
CEL Healthcare Fund |
|
|
|
|
|
|
| |
PARTICIPATING VENTURE FIRMS AND CORPORATIONS |
|
|
|
| |
PARTIAL PARTICIPATING COMPANIES |
| |
|
|
|
| |
PRELIMINARY AGENDA |
|
|
| |
| |
08:00-10:15 am |
Investors & Companies One-on-One Meetings / Company Exhibition
Continental Breakfast |
| |
10:15-10:20 am |
Welcoming Remarks
Yanhong Lin, Managing Partner, CTIC Capital |
| |
10:20-11:10 am |
Keynote & Award Ceremony - Creating and Implementing Novel Biomedical Technologies
Robert S. Langer, David H. Koch Institute Professor, MIT |
| |
11:10-11:40 am |
Fireside Chat: Precision medicine
Hemant Taneja, Managing Director, General Catalyst Partners
Elad Gil, CEO, Color Genomics |
| |
11:40-12:20 pm |
Panel Discussion – 2017 Cross Border Investment Opportunities and Challenges
Kevin Chen, Partner, Sequoia China
Steven Wang, Partner, Highlight Capital
Chen Yu, Vivo Capital
Kewen Jin, Chairman of BayHelix & Managing Partner, Serica Capital
Xiangyu Ouyang, Managing Director, Legend Capital |
| |
12:20-01:20 pm |
Lunch / One-on-One Meetings |
| |
01:20-01:40 pm |
Keynote - Innovation and Collaboration Ecosystem and Platform
Steve Yang, SVP and COO, WuXi AppTec |
| |
01:40-02:20 pm |
Panel Discussion II – US China Partnerships and M&A Opportunities
Victor Shi, Founding President, QIAGEN Asia Pacific; General Partner, Serica Capital
Jennifer Hu, Partner, Qiming Ventures
Richard Zhao, GM Strategy and Investment & Senior Vice President, Medical Device
Steven Wang, Managing Director, CITIC PE
Jimmy Zhang, CLI Ventures |
| |
02:20-03:00 pm |
Panel Discussion III – Future of US Healthcare Investments (where would the funding go in 2017 and beyond)
Skip Fleshman, Managing Partner, AMV
David Berry, General Partner, Flagship Ventures
Ted Driscoll, Partner, Decheng Capital
Neil Exter, Partner, Third Rock Ventures |
| |
03:00-03:10 pm |
Break |
| |
03:10-04:00 pm |
Breakout Panel A - Future of In Vitro Diagnostic Tools
Yaoming Liang, Chairman, KingMed Diagnostics
Dongliang Ge, President, BioScikin Co.
Breakout Panel B - New Drug Development: The Promise and The Pitfalls
Frank Jiang, CEO, CStone Pharmaceuticals
Vincent Xiang, Partner, Frontline BioVentures
Dajun Yang, CEO, Ascentage Pharma Group
Breakout Panel C - Medical Device & MedTech: Is China the New Exit
Christopher von Jako, President and CEO, NinePoint Medical
Clarence Kho, Managing Director, Converge Minds
Bin Sun, Managing Director, CEL Healthcare Fund |
| |
04:00-06:00 pm |
One-on-One Meetings and Networking |
| |
|
|
|
| |
CONTACT US |
| |
 |
 |
ning.feng@cticcapital.com |
|
|
|
yanhong.lin@cticcapital.com |
| |
|
|
|
